Safety and Effectiveness of Short-Term Single AntiPlatelet Therapy After Left Atrial Appendage Closure With the LAmbre Device in Patients With Nonvalvular Atrial Fibrillation: A Multinational Real-world Registry

NCT06620757 · clinicaltrials.gov ↗

RECRUITING

Status

234

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Single antiplatelet therapy (SAPT)

Sponsor

Fundación EPIC